🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prospective Cohort of Diagnostic Bronchoscopy for Peripheral Lung Lesions

Recruitingn/aAges 19 Years - anyAllSeoul National University Bundang Hospital
NCT05804786 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The primary objective is To evaluate the usefulness and safety of advanced guided bronchoscopy for histological diagnosis of peripheral pulmonary lesions. The Secondary objective is to establish a strategy that can most effectively use endoscopes for early diagnosis of lung cancer in a real-world care environment by identifying patient/clinical/image/procedure-related characteristics that can optimize the practicality of emerging technologies.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Patients who agreed in writing to participate in this study 2. Adult men and women over 19 years of age 3. Patients who visited the hospital with lung lesions suspected of lung cancer and require a diagnostic biopsy 4. Patients capable of biopsy through guided bronchoscopy Exclusion Criteria: 1\) Patients who are unable to express their opinions and cannot cooperate due to a lack of cognitive function
💊

What it tests

  • Guided bronchoscopy
📍

Where

11 sites
Dongsan Hospital Keimyung University School of Medicine
Daegu, South Korea
Hallym University Dongtan Sacred Heart Hospital
Gyeonggi-do, South Korea
Chunnam National University Hwasun Hospital
Hwasun, South Korea
Inje University Ilsan Paik Hospital
Ilsan, South Korea
Gyeongsang National University Hospital
Jinju, South Korea
Seoul National University Bundang Hospital
Seongnam-si, South Korea
Asan Medical Center, University of Ulsan College of Medicine
Seoul, South Korea
Gangnam Severence Hospital
Seoul, South Korea

…and 3 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy